In the Q4 2011, ExlService Holdings Inc - EXLS - achieved record revenues of $102.6M, a 46.5% increase year over year. Cumberland Pharmaceuticals Inc - CPIX - reported that it has entered into an exclusive agreement with China’s Harbin Gloria Pharmaceuticals for the commercialization of Acetadote (acetylcysteine) and Caldolor (ibuprofen) Injection. According to The company, In exchange for the license to the product, Cumberland will receive upfront and milestone licensing payments, as well as royalties on future sales of both drugs. For the Q4 of 2011, Crexendo Inc - EXE - posted Net income of $459,000, compared to a net loss of $2,405,000 in the same period the prior year ***** THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)
投稿者: karmastock
投稿日時:2012-02-29 15:19:14.0
視聴回数:507回
お気に入り登録:0
カテゴリ:
ビジネス全般
タグ:
EXLS
CPIX
EXE
Amex:EXE
Nasdaq:CPIX
Nasdaq:EXLS
On its Second Quarter Fiscal 2012, Globecomm Systems Inc - GCOM - posted revenue of $95.2 million, a 35.5% increase year over year. Exelixis Inc - EXEL - reported results for the fourth quarter 2011, posting revenues of $93.3 million, compared to $40.8 million for the comparable period in 2010. Cumberland Pharmaceuticals Inc - CPIX - reported that it has received a Notice of Allowance from the United States Patent and Trademark Office relating to its new formulation of Acetadote (acetylcysteine) Injection, which is used to treat acetaminophen poisoning. ********************* THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://crwenewswire.com/disclaimer).
投稿者: karmastock
投稿日時:2012-02-09 11:40:39.0
視聴回数:349回
お気に入り登録:0
カテゴリ:
ビジネス全般
タグ:
acetylcysteine
acetaminophen
Cumberland
Globecomm
Exelixis
GCOM
EXEL
CPIX
Nasdaq:CPIX
Nasdaq:EXEL
Nasdaq:GCOM